Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Mitchell, Jonathan S ^a   Johnson, David C ^a   Litchfield, Kevin ^a   Broderick, Peter ^a   Weinhold, Niels ^b   Davies, Faith E ^a   Gregory, Walter A ^c   Jackson, Graham H ^d   Kaiser, Martin ^a   Morgan, Gareth J ^b   Houlston, Richard S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b Myeloma Institute for Research and Therapy   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; CASE CONTROL STUDY; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN GENOME; MULTIPLE MYELOMA; PATHOLOGY; PHENOTYPE; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MODELS, GENETIC; MULTIPLE MYELOMA; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE;

EID: 84937879795     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12473     Document Type: Article

References (26)

1. Kyle, R. A. & Rajkumar, S. V. Multiple myeloma. N Engl J Med 351, 1860-73 (2004).
2. Kyle, R. A. et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346, 564-9 (2002).
3. Altieri, A., Chen, B., Bermejo, J. L., Castro, F. & Hemminki, K. Familial risks and temporal incidence trends of multiple myeloma. Eur J Cancer 42, 1661-70 (2006).
4. Morgan, G. J. et al. Inherited genetic susceptibility to multiple myeloma. Leukemia 28, 518-24 (2014).
5. Broderick, P. et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat Genet 44, 58-61 (2012).
6. Chubb, D. et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet 45, 1221-5 (2013).
7. Weinhold, N. et al. The CCND1 c.870G> A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat Genet 45, 522-5 (2013).
8. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 88, 76-82 (2011).
9. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. Genome-wide complex trait analysis (GCTA): methods, data analyses, and interpretations. Methods Mol Biol 1019, 215-36 (2013).
10. Yang, J. et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet 43, 519-25 (2011).
11. Golan, D., Lander, E. S. & Rosset, S. Measuring missing heritability: Inferring the contribution of common variants. Proceedings of the National Academy of Sciences 111, E5272-E5281 (2014).
12. Lu, Y. et al. Most common 'sporadic' cancers have a significant germline genetic component. Hum Mol Genet 23, 6112-8 (2014).
13. Lee, S. H. et al. Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Hum Mol Genet 22, 832-41 (2013).
14. Yang, J. et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 42, 565-9 (2010).
15. Pritchard, J. K. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69, 124-37 (2001).
16. Sawyer, J. R. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma. Cancer Genet 204, 3-12 (2011).
17. Do, C. B. et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 7, e1002141 (2011).
18. Michailidou, K. et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45, 353-61 361-1-2 (2013).
19. Eeles, R. A. et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 45, 385-91 391-1-2 (2013).
20. Pharoah, P. D. et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 45, 362-70 370-1-2 (2013).
21. Pashayan, N. et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer 104, 1656-63 (2011).
22. Morgan, G. et al. MyelomA Genetics International Consortium. Leuk Lymphoma 53, 796-800 (2012).
23. Morgan, G. J. et al. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet 376, 1989-99 (2010).
24. Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 35, 34-41 (2006).
25. Clayton, D. G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 37, 1243-6 (2005).
26. McLaren, W. et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26, 2069-70 (2010).